Simultaneous multi-vessel subacute stent thromboses in zotarolimus-eluting stents

Citations

SCOPUS

0

초록

Despite its low incidence, stent thrombosis (ST) is one of the most dreaded complications of percutaneous coronary intervention. Endeavor (Medtronics Europe SA) is a new zotarolimus-eluting stent (ZES) with a favorable safety profile that was reported in early and ongoing trials. However, few lethal stent thromboses related to this new drug eluting stent (DES) have been reported. We experienced a case of simultaneous subacute ZES thromboses, 6 days after stent implantations in the proximal left anterior descending artery and the proximal right coronary artery (RCA). Copyright © 2010 The Korean Society of Cardiology.

키워드

Drug-eluting stents; Stents; Thrombosis; Zotarolimus; acetylsalicylic acid; cilostazol; clopidogrel; low molecular weight heparin; zotarolimus; adult; angiocardiography; article; blood clot lysis; case report; drug eluting stent; drug safety; dyspnea; electrocardiogram; emergency ward; female; heart infarction; heart ventricle fibrillation; human; left anterior descending coronary artery; lung congestion; percutaneous coronary intervention; right coronary artery; ST segment elevation; stent thrombosis; thorax pain; thorax radiography
제목
Simultaneous multi-vessel subacute stent thromboses in zotarolimus-eluting stents
저자
Kim Y.-H.; Suh, Soon Yong; Kim S.H.; Lim S.-Y.; Roh S.-Y.; Kim J.-B.; Song W.H.; Ahn J.C.
DOI
10.4070/kcj.2010.40.5.243
발행일
2010-05
유형
Article
저널명
Korean Circulation Journal
권
40
호
5
페이지
243 ~ 246